Inc. (NASDAQ:OM), a medical technology company focused on innovating dialysis treatment, has resolved all concerns raised in a Warning Letter from the U.S. Food and Drug Administration (FDA) dating ...

The neurologist explains the link between Guillain-Barre Syndrome and paralysis, and the initial symptoms to watch out for.

Moleculin Biotech, Inc., ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it ...

SAN ANTONIO - As technology continues to advance, so does artificial intelligence and how it is being used in almost ...

He ended up down an embankment and suffered a broken back but managed to drag himself back onto the road to try and check on people in other car.

DaVita Inc. announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating ...

The US Food and Drug Administration (FDA) has approved the first oral treatment for anaemia caused by chronic kidney disease (CKD) in adults on dialysis for at least four months: GlaxoSmithKline ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 –– ...